Boston Scientific Corp logo

Boston Scientific Corp

$ 41.20 (0%) Jun 28
P/E:
68.76
P/B:
3.31
Market Cap:
$ 53.61B
Enterprise V:
$ 62.97B
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
53.61B
PE Ratio:
68.76
Avg Vol (2-Month):
-
Enterprise Value $:
62.97B
PB Ratio:
3.31
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset 0.54
Debt-to-Equity 0.54
Debt-to-EBITDA 3.41
Interest Coverage 3.75
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.84
Distress
Grey
Safe
Beneish M-Score -2.31
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.31
Quick Ratio 0.86
Cash Ratio 0.07
Days Inventory 152.74
Days Sales Outstanding 52.73
Days Payable 67.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1

Financials (Next Earnings Date:2022-10-27 Est.)

LIM:BSX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 12,329
EPS (TTM) ($) 0.41
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 41.2
12-1 Month Momentum % 0
52-Week Range ($) 41.2 - 41.2
Shares Outstanding (Mil) 1,429.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Boston Scientific Corp Filings

Document Form Filing Date
No Filing Data

Boston Scientific Corp Analysis

Share your research